The FDA's controversial plan to make prescription drugs available over the counter has sparked debate. Commissioner Marty Makary believes that most medications should be accessible without a prescription, but this idea has faced criticism from the pharmaceutical industry. In an interview, Makary emphasized the potential benefits of OTC drugs, including reduced healthcare costs and improved accessibility. However, some argue that this move could increase costs for patients and raise concerns about self-selection. The FDA's efforts to streamline the regulatory process have been met with mixed reactions, as the agency navigates the delicate balance between accessibility and safety. Will the public embrace this change, or will it lead to unforeseen consequences? The debate continues as the FDA weighs the pros and cons of OTC medications.
